The opioid crisis has created an environment of risk for health insurance providers as it relates to managing member care, appropriate levels of drug testing, and managing withdrawals and substance use disorders.
This webinar will discuss the current trends and status of the opioid epidemic, and how evidence-based, behavioral health care guidelines can support health care professionals seeking to mitigate risks and improve care delivery.
Doug Kalunian, MD, DFAPA,
Physician Editor, Behavioral Health
Dr. Kalunian is a Physician Editor responsible for researching and writing MCG’s Behavioral Health Care guidelines. Before joining MCG in 2017, Dr. Kalunian was Medical Director of the Behavioral Health Access and Utilization Management unit at Kaiser Permanente of Washington (formerly Group Health Permanente). His prior clinical roles include serving as Director of an inpatient geriatric psychiatric unit at McLean Hospital, Director of an outpatient and consultation liaison geriatric psychiatry service at The George Washington University, and owner of a solo geriatric and adult psychiatry private practice in California. He received his medical degree from St. Louis University and completed his psychiatric residency at UCSF Langley Porter Psychiatric Institute, and his geriatric psychiatry fellowship at McLean Hospital. He is board-certified in both Adult and Geriatric Psychiatry and is a Distinguished Fellow of the American Psychiatric Association.